Literature DB >> 31072138

Identification of novel blood-based HCC-specific diagnostic biomarkers for human hepatocellular carcinoma.

Li Yin1, Na He1, Chuizhe Chen1, Nan Zhang1, Yingzi Lin1, Qianfeng Xia1.   

Abstract

INTRODUCTION: Hepatocellular carcinoma (HCC) ranks fourth in global cancer mortality, accounting for 8.2% of all cancer deaths. Early detection of HCC has a significant impact on clinical outcomes. The aim of this study was to identify blood-based biomarkers which are HCC-specific.
METHODS: Comprehensive gene expression raw data of purified RNA of peripheral blood mononuclear cells (PBMC) was downloaded from GEO and was then analyzed. Differentially expressed genes (DEGs) in HCC were screened and the method of weighted gene co-expression network analysis was applied to identify candidate blood-based biomarkers associated with HCC.
RESULTS: Three modules closely related to HCC were screened using WGCNA. Nuclear localization signal (NLS)-bearing protein import into nucleus biological process was the most significant enriched physiological process identified by MCODE, and 3 genes (DICER1, GMPS and NCOR1) were selected as biomarkers.
CONCLUSION: In our study, three novel blood-based HCC-specific diagnostic biomarkers for human hepatocellular carcinoma were identified. These findings may contribute to the non-invasive detection of early HCC patients.

Entities:  

Keywords:  Peripheral blood mononuclear cells (PBMC; WGCNA; biomarker; human hepatocellular carcinoma (HCC)

Mesh:

Substances:

Year:  2019        PMID: 31072138     DOI: 10.1080/21691401.2019.1613421

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  12 in total

1.  A novel immune signature to predict the prognosis of patients with hepatocellular carcinoma.

Authors:  Qinghe Li; Bin Fan; Jun Ding; Xiaoxi Xiang; Jian Zhang
Journal:  Medicine (Baltimore)       Date:  2021-08-20       Impact factor: 1.817

2.  Single-Cell RNA-seq Analysis Reveals Dysregulated Cell-Cell Interactions in a Tumor Microenvironment Related to HCC Development.

Authors:  Zhenhao Liu; Siwen Zhang; Jian Ouyang; Dan Wu; Lanming Chen; Wen Zhou; Lu Xie
Journal:  Dis Markers       Date:  2022-05-18       Impact factor: 3.464

3.  Comprehensive analysis of immune-related prognostic genes in the tumour microenvironment of hepatocellular carcinoma.

Authors:  Weike Gao; Luan Li; Xinyin Han; Siyao Liu; Chengzhen Li; Guanying Yu; Lei Zhang; Dongsheng Zhang; Caiyun Liu; Erhong Meng; Shuai Hong; Dongliang Wang; Peiming Guo; Guangjun Shi
Journal:  BMC Cancer       Date:  2021-03-31       Impact factor: 4.430

4.  Six Metabolism Related mRNAs Predict the Prognosis of Patients With Hepatocellular Carcinoma.

Authors:  Xiwen Wu; Tian Lan; Muqi Li; Junfeng Liu; Xukun Wu; Shunli Shen; Wei Chen; Baogang Peng
Journal:  Front Mol Biosci       Date:  2021-02-25

5.  Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma.

Authors:  Weiyang Cai; Wenming Bao; Shengwei Chen; Yan Yang; Yanyan Li
Journal:  Cancer Cell Int       Date:  2021-12-20       Impact factor: 5.722

Review 6.  Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma.

Authors:  Yang Yang; Guangbing Li; Ziwen Lu; Yong Liu; Junjie Kong; Jun Liu
Journal:  Front Oncol       Date:  2021-11-10       Impact factor: 6.244

7.  Identification of a novel gene signature for the prediction of recurrence in HCC patients by machine learning of genome-wide databases.

Authors:  Jie Shen; Liang Qi; Zhengyun Zou; Juan Du; Weiwei Kong; Lianjun Zhao; Jia Wei; Ling Lin; Min Ren; Baorui Liu
Journal:  Sci Rep       Date:  2020-03-10       Impact factor: 4.379

8.  Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients.

Authors:  Devis Pascut; Muhammad Yogi Pratama; Francesca Gilardi; Mauro Giuffrè; Lory Saveria Crocè; Claudio Tiribelli
Journal:  Sci Rep       Date:  2020-11-03       Impact factor: 4.379

9.  Identification of Diagnostic Biomarkers and Subtypes of Liver Hepatocellular Carcinoma by Multi-Omics Data Analysis.

Authors:  Xiao Ouyang; Qingju Fan; Guang Ling; Yu Shi; Fuyan Hu
Journal:  Genes (Basel)       Date:  2020-09-06       Impact factor: 4.096

10.  Dexmedetomidine promotes apoptosis and suppresses proliferation of hepatocellular carcinoma cells via microRNA-130a/EGR1 axis.

Authors:  Lei Zhou; Juanni Li; Xing Liu; Yongzhong Tang; Tunliang Li; Huiyin Deng; Jia Chen; Xinlin Yin; Kuan Hu; Wen Ouyang
Journal:  Cell Death Discov       Date:  2022-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.